Nasdaq Most Active

Prism Marketview
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out

Home markets Page 3

Tag: markets

AstraZeneca is investing $2 billion in Summit Therapeutics at a 10% premium and pairing ivonescimab with Sone-Ve in GI cancers. SMMT jumped 25% premarket.
September 29, 2026

Summit Therapeutics Lands $2 Billion From AstraZeneca — at a Premium, Not a Discount

Summit Therapeutics (SMMT) shares jumped roughly 25% in premarket trade Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in the clinical-stage oncology company and…

Marvell AI revenue could rise $2B+ on its Google custom chip deal, RBC says. MRVL investor day Oct. 6; RBC keeps Outperform, $360 target.
September 28, 2026

Marvell Poised to Raise AI Revenue Target by $2B+ on Google Deal, RBC Says

Marvell Technology (NASDAQ: MRVL) is likely to raise its fiscal 2029 AI revenue forecast by at least $2 billion, according to RBC Capital Markets. In…

MongoDB CEO Chirantan Desai exits for Meta's new enterprise AI unit. MDB falls 18% as Dev Ittycheria returns as interim CEO and guidance holds.
September 28, 2026

MongoDB Shares Sink 18% as CEO Chirantan Desai Exits for Meta

MongoDB (NASDAQ: MDB) lost its chief executive on Monday. Chirantan Desai is leaving after less than a year in the job to become chief enterprise…

Microsoft (NASDAQ: MSFT) unveils Autopilot, unifying Copilot's chat, coding and agentic AI. CEO Satya Nadella says user trust is the biggest hurdle.
September 25, 2026

Microsoft Corporation Launches Autopilot and Makes User Trust the Center of Its Enterprise AI Push

Microsoft Corporation (NASDAQ: MSFT) on Friday launched Autopilot, a new version of its Copilot platform that puts chat, coding and agentic AI into one enterprise…

The FDA cleared Satellos Bioscience's FSHD IND for forazapadin, and a patient foundation is funding the Phase 2 with $5M in non-dilutive capital.
September 24, 2026

Satellos Bioscience Clears FDA Hurdle for Second Indication — and Funds It Without Dilution

Satellos Bioscience (MSLE) announced Thursday that the US Food and Drug Administration cleared its Investigational New Drug application for forazapadin in facioscapulohumeral muscular dystrophy, opening…

Beneficient (NASDAQ: BENF) stock soared 439% after unveiling a plan to erase $130M in disputed debt and $850M in preferred equity tied to its ex-CEO.
September 24, 2026

Beneficient Surges 439% on Plan to Wipe Out Former CEO’s Debt and Equity Claims

Beneficient (NASDAQ: BENF) shares jumped 438.73% on Wednesday to close at $2.90. The rally came after the alternative-asset liquidity provider announced a plan to cut…

https://www.dropbox.com/scl/fi/43iyxzcv7mm6govfa3oew/Screenshot-2026-09-24-at-8.32.20-AM.png?rlkey=97idoxctlx4z2zrx9t1uefd6c&dl=0
September 24, 2026

Boeing Scales Back China Hopes as Trump-Xi Summit Arrives

Boeing Company (NYSE: BA) is heading into Thursday’s summit between President Donald Trump and Chinese President Xi Jinping with lower expectations. Rather than chasing a…

KB Home cut full-year margin guidance as the 30-year mortgage rate hit 7.12%. With October Fed hike odds at 69%, the homebuilder squeeze is just starting.
September 23, 2026

KB Home Cuts Margin Guidance as Mortgage Rates Cross 7% — and the Fed Isn’t Done

KB Home (KBH) beat Wall Street on third-quarter earnings and the stock fell anyway. The homebuilder cut its full-year housing gross margin guidance late Tuesday,…

McDonald's NEXT strategy targets 1.5 points of chicken and beverage share by 2030 plus $8.5B in franchisee support. MCD fell over 4% on slow growth.
September 23, 2026

McDonald’s Bets on Chicken and Cold Drinks — Investors Mark the Stock Down

McDonald’s (MCD) used its first investor day in nearly three years to unveil “NEXT,” a strategy built to reverse sliding US traffic and restore franchisee…

USA Rare Earth (USAR) anchors America's rare earth push. What its $1.6B Commerce deal and the Trump–Xi summit mean for investors.
September 23, 2026

USA Rare Earth Takes Center Stage in America’s Rare Earth Push as Trump–Xi Summit Nears

USA Rare Earth (Nasdaq: USAR) has become one of the clearest ways for investors to bet on Washington’s plan to break China’s hold on rare…

Viking Therapeutics (VKTX) jumped 36% after VK2735 obesity data showed 16–19% weight loss and up to 97% maintained with less frequent dosing.
September 23, 2026

Viking Therapeutics Shares Jump 36% After New Obesity Data Shows Patients Keep the Weight Off

Viking Therapeutics (Nasdaq: VKTX) shares rose 35.7% to close at $40.85 on Tuesday. The rally followed new clinical data for VK2735, the company’s experimental weekly…

Novo Nordisk set 2035 growth targets ahead of its semaglutide patent expiration. NVO fell 8% as guidance only matched peers. Key numbers and what's next.
September 21, 2026

Novo Nordisk Maps Its Post-Semaglutide Future — and Investors Sell the Plan

Novo Nordisk (NVO) laid out its long-term growth ambitions at a capital markets day in London on Monday, and shareholders responded by marking the stock…

Posts pagination

Previous page Page 1 Page 2 Page 3 Page 4 … Page 135 Next page

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup

News

  • Latest
  • PRISM View
  • Biotech
  • Finance
  • Healthcare
  • Technology

Indexes

  • Aerospace & Defense
  • AI Datacenter and Infrastructure
  • Biotech
  • Cannabis
  • Comms and Media
  • Consumer Products
  • Crypto Mining
  • Cybersecurity
  • EV
  • Fintech
  • Global Health
  • Healthcare
  • MedDevices
  • Mental Health
  • New Energy
  • NextGen Tech & AI
  • Oil & Gas
  • Pet Care
  • Pharmaceuticals
  • Psychedelics
  • Semiconductors
  • Space
  • Sports
  • Weight Loss
  • Wellness
  • Women’s Health
  • Home
  • About Us
  • Contact Us

Copyright © 2026 PRISM MarketView. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
  • Disclaimer